Published in Clin Transplant on February 09, 2009
Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev (2010) 1.68
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One (2017) 1.38
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. J Clin Immunol (2010) 0.87
Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant (2012) 0.87
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients. Transplantation (2013) 0.86
Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J (2010) 0.81
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
IFNalpha activates dormant haematopoietic stem cells in vivo. Nature (2009) 7.17
Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med (2006) 2.73
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis (2012) 2.48
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Blood (2009) 2.28
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension (2004) 1.89
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol (2010) 1.82
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin Infect Dis (2008) 1.72
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood (2010) 1.70
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol (2008) 1.70
Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J Virol (2004) 1.68
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant (2004) 1.54
Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant (2007) 1.43
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. Bioorg Med Chem (2010) 1.40
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics. Clin Pharmacokinet (2010) 1.27
New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol (2009) 1.27
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain (2008) 1.24
Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation (2004) 1.22
Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion (2012) 1.22
Stored red blood cells: a changing universe waiting for its map(s). J Proteomics (2009) 1.19
Two-stage Off-Gel isoelectric focusing: protein followed by peptide fractionation and application to proteome analysis of human plasma. Electrophoresis (2005) 1.19
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis (2011) 1.17
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest (2008) 1.16
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation (2008) 1.16
Sensitization after kidney transplantation. Clin J Am Soc Nephrol (2006) 1.09
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol (2009) 1.09
Recent advances in blood-related proteomics. Proteomics (2005) 1.09
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clin Infect Dis (2013) 1.08
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood (2006) 1.07
Generation and phenotypic analysis of protein S-deficient mice. Blood (2009) 1.06
Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII. J Biol Chem (2004) 1.05
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med (2007) 1.04
Identification of swiprosin 1 in human lymphocytes. Proteomics (2004) 1.04
CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. Ther Drug Monit (2008) 1.04
Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics (2003) 1.04
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis (2006) 1.03
Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial. BMC Med (2012) 0.99
Plasma/serum proteomics: pre-analytical issues. Expert Rev Proteomics (2007) 0.99
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients. Pharmacogenet Genomics (2008) 0.99
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Leuk Res (2007) 0.98
Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action. Int Immunopharmacol (2009) 0.98
Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. J Proteomics (2012) 0.98
Retracted Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol (2009) 0.97
Microparticles in stored red blood cells: submicron clotting bombs? Blood Transfus (2010) 0.97
Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis (2013) 0.96
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis (2013) 0.96
IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis (2002) 0.95
The role of proteomics in the assessment of premature rupture of fetal membranes. Clin Chim Acta (2005) 0.95
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PLoS One (2013) 0.95
Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation (2006) 0.94
Humoral rejection of organ allografts. Am J Transplant (2005) 0.94
Update in renal transplantation. Arch Intern Med (2004) 0.94
Intrathecal immune responses to EBV in early MS. Eur J Immunol (2010) 0.94
Red blood cell microparticles: clinical relevance. Transfus Med Hemother (2012) 0.93
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation (2007) 0.92
Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. Drugs (2008) 0.92
Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther (2003) 0.91
Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51. J Biol Chem (2002) 0.91
Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health (2010) 0.91
Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol (2008) 0.91
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol (2013) 0.91
Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant (2004) 0.91
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation (2005) 0.90
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood (2013) 0.90
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. Antivir Ther (2008) 0.89
A Fas agonist induces high levels of apoptosis in haematological malignancies. Leuk Res (2005) 0.89
Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. Blood Transfus (2012) 0.89
Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta (2010) 0.88
Myths: history, blood, sex and money. Blood Transfus (2012) 0.88
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation (2010) 0.87
New treatments for acute humoral rejection of kidney allografts. Expert Opin Investig Drugs (2007) 0.87
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood (2006) 0.87
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant (2011) 0.87
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation. Transpl Immunol (2008) 0.86
Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol (2004) 0.86
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int (2007) 0.86
Individualising HIV treatment--pharmacogenetics and immunogenetics. Lancet (2002) 0.86
The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro. J Gen Virol (2004) 0.86
MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells. Pathobiology (2008) 0.86
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma. Glia (2010) 0.86
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS One (2012) 0.86
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Leuk Res (2007) 0.86
Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol (2007) 0.85
From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int (2007) 0.85
Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide. J Infect Dis (2014) 0.85
Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int (2009) 0.84